RS
SRPT icon

Rakuten Securities’s Sarepta Therapeutics SRPT Stock Holding History

Rakuten Securities’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$39 – 968
2025
Q3 		$39 Sell
2
-185
-99% -$3.3K ﹤0.01% 894
2025
Q2 		$3.2K Buy
187
+126
+207% +$5.38K ﹤0.01% 548
2025
Q1 		$3.89K Buy
61
+4
+7% +$421 ﹤0.01% 516
2024
Q4 		$6.93K Buy
57
+17
+43% +$2.08K ﹤0.01% 435
2024
Q3 		$5K Buy
40
+23
+135% +$3.18K ﹤0.01% 419
2024
Q2 		$2.69K Buy
17
+13
+325% +$1.67K ﹤0.01% 458
2024
Q1 		$518 Sell
4
-4
-50% -$490 ﹤0.01% 613
2023
Q4 		$771 Buy
+8
New +$767 ﹤0.01% 490

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Rakuten Securities's SRPT Position: Q4 2025 in Review

Rakuten Securities sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 2 shares — an estimated $39 sold.

Rakuten Securities first reported a position in SRPT in Q4 2023 and held it in 8 quarters. The position peaked at $6.93K in Q4 2024. 347 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Rakuten Securities reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Rakuten Securities sold 2 Sarepta Therapeutics shares in Q4 2025, an estimated $39.
  • Rakuten Securities first reported a position in Sarepta Therapeutics in Q4 2023 and held it in 8 quarters.
  • Rakuten Securities's Sarepta Therapeutics position peaked at $6.93K in Q4 2024.
  • 347 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Rakuten Securities's 13F filing for Q4 2025, filed 29 Jan 2026.